1. EP-1728 1-year experience with automated transit in vivo dosimetry in a busy multicenter department. (April 2019) Authors: Bossuyt, E.; Weytjens, R.; De Vos, S.; Gysemans, R.; Verellen, D. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0079 EPID in vivo dosimetry implementation world-wide: results of an ESTRO survey. (August 2021) Authors: Esposito, M.; van de Kamer, J.B.; Bossuyt, E.; Kry, S.F.; Verellen, D.; Clark, C.; Jornet Sala, N. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-0809 Assessing the impact of adaptations to the clinical workflow using transit in vivo dosimetry. (May 2022) Authors: Bossuyt, E.; Taieb Mokaddem, A.; Weytjens, R.; Nevens, D.; Joye, I.; De Vos, S.; Verellen, D. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PH-0050: Results of 2 years of automated pretreatment and absolute transit in vivo dosimetry. (November 2020) Authors: Bossuyt, E.; Weytjens, R.; Nevens, D.; De Vos, S.; Verellen, D. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PH-0432 Treatment uncertainty for ultra- vs. standard-hypofractionated breast RT based on in-vivo dosimetry. (August 2021) Authors: Fiagan, Y.A.C.; Bossuyt, E.; Machiels, M.; Nevens, D.; Billiet, C.; Poortmans, P.; Gevaert, T.; Verellen, D. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-1836: Impact of bladder and rectum preparation on in vivo dosimetry for prostate cancer patients. (November 2020) Authors: Fiagan, Y.A.C.; Bossuyt, E.; Nevens, D.; Dirix, P.; Theys, F.; Verellen, D. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1974 The use of in-vivo dosimetry to detect head and neck cancer patients needing adaptive radiotherapy. (August 2021) Authors: FIAGAN, Y.A.C.; Nevens, D.; Bossuyt, E.; Machiels, M.; Chiairi, I.; Joye, I.; Paul, M.; Gevaert, T.; Verellen, D. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SP-0028 Large scale clinical implementation of in vivo dosimetry - What value does it bring?. (August 2021) Authors: Bossuyt, E. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗